CAT and ovarian carcinoma: In the present study, we demonstrated that VC F7 is able to inhibit cell proliferation, induce DNA damage and cell cycle arrest at the S-phase checkpoint of the cell cycle in human ovarian cancer (OVAR-3) cells through oxidative stress, as demonstrated by an increase in MDA production and a decrease in catalase and glutathione activities in treated cells compared to the control.